Discover 480 paid clinical trials in Conway, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 480
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Little Rock AR, Germantown TN, St Louis MO, Dallas TX,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
for
Benign Prostatic Hyperplasia
Location: Little Rock AR, Shreveport LA, Houston TX, Austin TX,
Sponsor: Urotronic Inc.
Sex: Male
Age: 50+
Code: NCT06312722
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Little Rock AR, Dallas TX, Kansas City KS, Nashville TN,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase 1, Phase 2, Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: Little Rock AR, Tulsa OK, Dallas TX, Wichita KS,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase 3, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Little Rock AR, Southaven MS, Germantown TN,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostatic Neoplasms, Castration-Resistant
Location: Little Rock AR, Jackson MS, St Louis MO, Dallas TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07225946
Phase 3, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Little Rock AR, St Louis MO, Dallas TX, Arlington TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
for
Bladder (Urothelial, Transitional Cell) Cancer,
Location: Little Rock AR, St Louis MO, Arlington TX, Houston TX,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT07480356
Phase 3, Recruiting
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
for
Muscle-invasive Bladder Cancer
Location: Little Rock AR, Round Rock TX, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07475806
Phase 2, Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer